Lachy McLean

2.3k total citations
23 papers, 1.7k citations indexed

About

Lachy McLean is a scholar working on Molecular Biology, Immunology and Rheumatology. According to data from OpenAlex, Lachy McLean has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Rheumatology. Recurrent topics in Lachy McLean's work include Musculoskeletal synovial abnormalities and treatments (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Lachy McLean is often cited by papers focused on Musculoskeletal synovial abnormalities and treatments (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Lachy McLean collaborates with scholars based in United States, New Zealand and United Kingdom. Lachy McLean's co-authors include Elizabeth Robinson, Sue Yeoman, Neal Stewart, J P Crabbe, Fiona McQueen, David Perry, Simon Bowman, Nandita Murukutla, Frederick B. Vivino and Barbara Segal and has published in prestigious journals such as Blood, The Journal of Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Lachy McLean

23 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lachy McLean United States	12	1.1k	402	244	213	199	23	1.7k
Olivier Bénichou United States	25	949 0.9×	518 1.3×	326 1.3×	159 0.7×	358 1.8×	35	1.7k
Stephanie Finzel Germany	25	1.4k 1.3×	347 0.9×	100 0.4×	300 1.4×	288 1.4×	86	1.9k
Mario Salazar-Páramo Mexico	20	656 0.6×	130 0.3×	123 0.5×	128 0.6×	238 1.2×	92	1.4k
B. L. Hazleman United Kingdom	17	652 0.6×	341 0.8×	80 0.3×	183 0.9×	149 0.7×	29	1.7k
Kwi Young Kang South Korea	21	677 0.6×	144 0.4×	145 0.6×	76 0.4×	247 1.2×	66	1.3k
Ali Askari United States	19	531 0.5×	185 0.5×	115 0.5×	113 0.5×	196 1.0×	39	1.2k
Bert Vander Cruyssen Belgium	26	1.4k 1.4×	281 0.7×	50 0.2×	320 1.5×	261 1.3×	61	2.2k
Sławomir Jeka Poland	22	1.1k 1.1×	152 0.4×	120 0.5×	409 1.9×	159 0.8×	98	2.2k
Fabienne Coury France	16	440 0.4×	137 0.3×	140 0.6×	124 0.6×	306 1.5×	56	998
Javier del Pino‐Montes Spain	16	405 0.4×	198 0.5×	362 1.5×	78 0.4×	143 0.7×	42	1.1k

Countries citing papers authored by Lachy McLean

Since Specialization

Citations

This map shows the geographic impact of Lachy McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lachy McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lachy McLean more than expected).

Fields of papers citing papers by Lachy McLean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lachy McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lachy McLean. The network helps show where Lachy McLean may publish in the future.

Co-authorship network of co-authors of Lachy McLean

This figure shows the co-authorship network connecting the top 25 collaborators of Lachy McLean. A scholar is included among the top collaborators of Lachy McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lachy McLean. Lachy McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Esfandiari, Ehsanollah, Mary Chen, Glennda Smithson, et al.. (2021). A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Single‐Dose and Multiple‐Rising‐Dose Study of the BTK Inhibitor TAK‐020 in Healthy Subjects. Clinical and Translational Science. 14(3). 820–828. 3 indexed citations

Esfandiari, Ehsanollah, Hakop Gevorkyan, Hélène M. Faessel, et al.. (2018). SAT0226 A phase 1, randomized, double-blind, placebo-controlled, single- and multiple-rising dose study of the btk inhibitor tak-020 in healthy volunteers. Annals of the Rheumatic Diseases. 77. 974–974. 3 indexed citations

Fedyk, Eric R., et al.. (2018). A Single Administration of the Cytolytic CD38 Antibody TAK-079 to Healthy Subjects: Tolerability, Pharmacokinetics and Pharmacodynamics. Blood. 132(Supplement 1). 3249–3249. 6 indexed citations

Smithson, Glennda, Jonathan Zalevsky, Wouter Korver, Stefan Roepcke, & Lachy McLean. (2017). CD38+ cell depletion with TAK-079 reduces arthritis in a cynomolgus collagen-induced arthritis (CIA) model. The Journal of Immunology. 198(Supplement_1). 127.17–127.17. 6 indexed citations

Goldfarb, David S., et al.. (2013). Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones. Clinical Journal of the American Society of Nephrology. 8(11). 1960–1967. 51 indexed citations

Naik, Himanshu, Jingtao Wu, Robert Palmér, & Lachy McLean. (2012). The effects of febuxostat on the pharmacokinetic parameters of rosiglitazone, a CYP2C8 substrate. British Journal of Clinical Pharmacology. 74(2). 327–335. 13 indexed citations

Segal, Barbara, Simon Bowman, Philip C. Fox, et al.. (2009). Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States. Health and Quality of Life Outcomes. 7(1). 46–46. 156 indexed citations

Fox, Philip C., Simon Bowman, Barbara Segal, et al.. (2008). Oral involvement in primary Sjögren syndrome. The Journal of the American Dental Association. 139(12). 1592–1601. 83 indexed citations

McKinney, Cushla, Marilyn E. Merriman, Peter T. Chapman, et al.. (2007). Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Annals of the Rheumatic Diseases. 67(3). 409–413. 124 indexed citations

10.

Merriman, Marilyn E., John Highton, Peter T. Chapman, et al.. (2005). Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. Arthritis & Rheumatism. 52(7). 2222–2225. 64 indexed citations

11.

Wu, Lili, Robert P. Young, Graham Mills, et al.. (2004). Transforming growth factor-ß1 genotype and susceptibility to chronic obstructive pulmonary disease. Journal of Medical Genetics. 41(4). 285–285. 3 indexed citations

12.

McLean, Lachy. (2004). Tophaceous pseudotumors in Polynesian patients with gout.. PubMed. 31(9). 1866–8. 3 indexed citations

13.

McQueen, Fiona, David Perry, Elizabeth Robinson, et al.. (2003). Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis & Rheumatism. 48(7). 1814–1827. 334 indexed citations

14.

Dalbeth, Nicola, et al.. (2002). Audit of the management of suspected giant cell arteritis in a large teaching hospital. Internal Medicine Journal. 32(7). 315–319. 3 indexed citations

15.

Cooper, Carlton R., Lachy McLean, Michael Walsh, et al.. (2000). Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro.. PubMed. 6(12). 4839–47. 52 indexed citations

16.

Stewart, Neal, et al.. (1999). Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Annals of the Rheumatic Diseases. 58(3). 156–163. 243 indexed citations

17.

Stewart, Neal, et al.. (1998). Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Annals of the Rheumatic Diseases. 57(6). 350–356. 368 indexed citations

18.

McLean, Lachy, Robert E. Hammer, & Joel D. Taurog. (1996). Cytokine profiles and site-directed B27 mutation in the HLA-B27 transgenic rat. Human Immunology. 47(1-2). 74–74. 7 indexed citations

19.

Kimura, Lucille, et al.. (1991). Reaction of antibody to mycobacterial 65 kDa heat-shock protein with human chondrocytes. Journal of Autoimmunity. 4(6). 881–892. 4 indexed citations

20.

Winrow, V R, Lachy McLean, Christopher J. Morris, & David R. Blake. (1990). The heat shock protein response and its role in inflammatory disease.. Annals of the Rheumatic Diseases. 49(2). 128–132. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact